Stockreport

Positive 12-Month Data on BioCardia’s Investigational CardiAMP Cell Therapy System for Heart Failure Presented at American Heart Association Scientific Sessions 2018

BioCardia, Inc.  (BCDA) 
PDF CHICAGO & SAN CARLOS, Calif.--(BUSINESS WIRE)-- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascula [Read more]